Equities

Victrex PLC

Victrex PLC

Actions
Basic MaterialsChemicals
  • Price (GBX)2,354.00
  • Today's Change10.00 / 0.43%
  • Shares traded131.70k
  • 1 Year change+12.10%
  • Beta0.8736
Data delayed at least 20 minutes, as of Dec 03 2021 16:43 GMT.
More ▼
Take Action
Take Action
Add this security to watchlist, portfolio, or create an alert to track market movement

Profile data is unavailable for this security.

About the company

Victrex plc is a United Kingdom-based holding company. The Company is engaged in the manufacture and sale of various polymers. The Company's operating segments include Industrial (Victrex Polymer Solutions) and Medical (Invibio Biomaterial Solutions). The Victrex Polymer Solutions segment focuses on automotive, aerospace, electronics and energy markets. The Invibio Biomaterial Solutions segment focuses on providing specialist solutions for medical device manufacturers. The Company offers polyetheretherketone (PEEK) and polyaryletherketone (PAEK)-based polymer solutions. The Company's geographical locations include the United Kingdom; Europe, Middle East and Africa (EMEA); Americas, and Asia-Pacific. Its solutions are used in a range of applications, such as braking systems in automotive market, seal rings in energy market, mobile devices in electronics market and implanted devices in medical market. Its subsidiaries include Victrex Manufacturing Limited and Invibio Limited.

  • Revenue in GBP (TTM)265.60m
  • Net income in GBP53.80m
  • Incorporated1993
  • Employees978.00
  • Location
    Victrex PLCVictrex Technology Centre, Hillhouse International,THORNTON CLEVELEYS FY5 4QDUnited KingdomGBR
  • Phone+44 125 389 7700
  • Fax+44 125 389 7701
  • Websitehttp://www.victrexplc.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Crete Plastics SA279.02m42.63m420.81m1.16k9.871.567.881.511.831.8312.0111.580.86043.234.39291,560.8013.7111.2516.8614.0928.0524.9315.9412.013.1283.210.0305--5.493.4531.1322.9416.72--
Gurit Holding AG452.56m29.47m497.94m2.95k18.813.8213.001.1077.1778.781,185.11379.741.485.295.46187,820.709.0911.3814.2717.1320.1826.906.168.071.3812.810.285225.453.299.922.5615.528.7514.87
Aksa Akrilik Kimya Sanayii AS306.09m44.85m527.93m1.28k11.724.7110.121.722.532.5317.286.301.115.346.764,503,211.0016.207.5931.9113.7223.0920.0214.658.510.64947.670.448781.3512.7315.1558.4417.1413.4712.36
SP Group A/S273.43m22.07m599.01m2.51k26.894.7815.272.1915.6215.62193.5187.791.053.636.941,081,556.008.508.3712.2513.4127.4026.218.097.080.586224.340.0017.438.2110.547.5720.0115.0844.27
Organicheskiy Sintez Kazan PAO859.94m193.83m1.79bn8.26k9.072.337.862.0810.6610.6647.2241.561.056.2156.49--23.6721.3626.9624.2336.6435.2022.5720.271.72107.580.011960.96-13.29-1.74-29.11-14.718.670.8167
Solvac SA/NV175.78m168.98m2.03bn0.0012.030.8744--11.579.319.319.69128.090.0729------7.013.017.023.0698.0796.2996.1494.62----0.0519110.02-921.62---1,075.00----2.42
Victrex plc265.60m53.80m2.04bn978.0037.854.2226.937.680.61920.61923.065.550.47951.465.52271,574.709.6816.9010.5618.6351.5861.1620.1830.913.41101.140.028981.53-8.190.0758-41.34-8.28-9.58-0.2922
Nizhnekamskneftekhim PAO2.09bn325.19m2.12bn18.87k6.651.295.391.0117.4217.42112.1789.420.75297.5731.55--11.7811.8913.1313.1326.5123.5215.6412.552.1713.100.388450.98-13.96-0.2295-62.53-20.0228.26-29.99
Nolato AB909.11m81.77m2.12bn6.72k28.896.0017.772.343.673.6740.7617.641.177.777.871,629,371.0010.5612.1116.3418.1816.1415.888.998.591.1230.250.0056.9018.1814.6414.6513.928.68-30.69
Synthomer PLC2.14bn216.50m2.21bn4.18k9.332.486.991.030.50700.50705.001.900.9586--6.52511,591.809.506.1512.138.72--21.289.915.291.2114.880.456259.1812.6912.96-96.34-44.7818.737.64
Lenzing AG1.72bn92.54m2.41bn7.83k25.591.489.861.404.174.1779.6372.330.47233.667.30275,374.702.945.393.616.9329.4245.116.227.412.439.800.49548.27-22.45-3.75-94.89-45.2056.64--
SASA Polyester Sanayi AS596.26m97.38m2.86bn4.30k29.1412.7326.134.801.601.609.763.650.82914.5610.872,700,107.0013.5410.9921.7117.4821.6018.5516.3318.050.55222.350.673813.0782.4035.31-70.6634.57101.60--
HEXPOL AB1.27bn196.58m3.03bn4.70k16.083.4912.842.386.886.8844.4931.660.89128.326.553,367,473.0013.7711.5917.1514.5222.8821.5015.4511.271.3546.290.227262.89-13.443.64-8.630.22879.736.23
Data as of Dec 03 2021. Currency figures normalised to Victrex PLC's reporting currency: UK Pound GBX

Institutional shareholders

42.91%Per cent of shares held by top holders
HolderShares% Held
Sprucegrove Investment Management Ltd.as of 18 Nov 20206.54m7.52%
M&G Investment Management Ltd.as of 18 Nov 20204.81m5.54%
Troy Asset Management Ltd.as of 18 Nov 20204.12m4.74%
Baillie Gifford & Co.as of 18 Nov 20203.74m4.31%
Mondrian Investment Partners Ltd.as of 18 Nov 20203.36m3.86%
Royal London Asset Management Ltd.as of 18 Nov 20203.26m3.75%
Evenlode Investment Management Ltd.as of 18 Nov 20203.25m3.74%
Threadneedle Asset Management Ltd.as of 18 Nov 20203.09m3.55%
The Vanguard Group, Inc.as of 01 Nov 20212.59m2.98%
Schroder Investment Management Ltd.as of 18 Nov 20202.55m2.94%
More ▼
Data from 30 Sep 2021 - 29 Oct 2021Source: FactSet Research Systems Inc.
An LSEG Business
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.